At Owkin we use machine learning to develop better drugs for patients. In doing so, we aim for faster development of safe and more effective therapies. Owkin’s purpose is to empower researchers in hospitals, universities and the biopharma industry to i) understand why drug efficacy varies from patient to patient, ii) improve the drug development process and iii) to help identify the best drug for each individual patient to improve patient outcomes. We have created a research platform and a portfolio of solutions that help researchers generate new biological insights and accelerate the development of better drugs.
- North America
- Western Europe